You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

PLAQUENIL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Plaquenil, and what generic alternatives are available?

Plaquenil is a drug marketed by Concordia and is included in one NDA.

The generic ingredient in PLAQUENIL is hydroxychloroquine sulfate. There are fifteen drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the hydroxychloroquine sulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Plaquenil

A generic version of PLAQUENIL was approved as hydroxychloroquine sulfate by TEVA PHARMS on September 30th, 1994.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PLAQUENIL?
  • What are the global sales for PLAQUENIL?
  • What is Average Wholesale Price for PLAQUENIL?
Summary for PLAQUENIL
Drug patent expirations by year for PLAQUENIL
Drug Prices for PLAQUENIL

See drug prices for PLAQUENIL

Drug Sales Revenue Trends for PLAQUENIL

See drug sales revenues for PLAQUENIL

Recent Clinical Trials for PLAQUENIL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Incannex Healthcare LtdPhase 2
Ministry of Health & Welfare, KoreaPhase 3
Yoo-min KimPhase 3

See all PLAQUENIL clinical trials

Pharmacology for PLAQUENIL

US Patents and Regulatory Information for PLAQUENIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Concordia PLAQUENIL hydroxychloroquine sulfate TABLET;ORAL 009768-001 Approved Prior to Jan 1, 1982 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.